Martin Patricia A.
SEC CIK 1916764 · EDGAR
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 19:40 | 2026-07-10 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +766 | 18.9K | +4% | $0 | |
| 2026-04-10 20:51 | 2026-04-10 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +1,192 | 18.1K | +7% | $0 | |
| DM | 2026-03-17 | 2026-03-13 | CYPH | CYPHERPUNK TECHNOLOGIES INC. | Martin Patricia A. | Dir | M - OptEx | — | +168.8K | 168.8K | New | — |
| 2026-01-14 | 2026-01-12 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +3,650 | 16.9K | +28% | $0 | |
| 2025-10-14 | 2025-10-10 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +3,274 | 13.3K | +33% | $0 | |
| 2025-07-11 | 2025-07-10 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +3,750 | 9,981 | +60% | $0 | |
| 2025-04-11 | 2025-04-10 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +3,065 | 6,231 | +97% | $0 | |
| 2024-12-23 | 2024-12-19 | ANTX | AN2 Therapeutics, Inc. | Martin Patricia A. | Dir | A - Grant | $0.00 | +3,166 | 3,166 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations